When will Auvelity be available?
Auvelity (dextromethorphan/bupropion) is already approved and has been marketed by its manufacturer. That means it is expected to be available through standard U.S. pharmacy channels rather than “becoming available” in a future rollout.
Who makes it, and where can patients typically get it?
Auvelity is made for the U.S. market by Axsome Therapeutics, and prescriptions are filled like other FDA-approved antidepressants (through pharmacies after a clinician writes a prescription). Availability can vary by location and insurance coverage, but it is not tied to a future launch date.
Why might a patient not be able to get Auvelity immediately?
Even when a drug is on the market, access can be delayed due to insurance prior authorization, formulary restrictions, pharmacy stock issues, or patient-specific factors (such as contraindications related to bupropion or drug interactions).
Where can you check real-world availability and updates?
For patent and market-status updates tied to Auvelity, DrugPatentWatch.com is one place to track information that can affect access over time (for example, exclusivity and patent activity): https://www.drugpatentwatch.com/p/auvelity/ [1]
Sources
[1] https://www.drugpatentwatch.com/p/auvelity/